Inventor · disambiguated record
Raluca Verona
Also filed as: VERONA RALUCA · VERONA RALUCA I
6 granted patents·9 pending applications·12 citations·filing 2016–2024
74Inventor score
Top patents by PatentIndex Score
15 records- 0188US10894830B2Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their usesJANSSEN BIOTECH INC·Filed 2016·Granted Jan 19, 2021·7 cites·21 claims
- 0281US10478494B2FGFR/PD-1 combination therapy for the treatment of cancerASTEX THERAPEUTICS LTD·Filed 2016·Granted Nov 19, 2019·5 cites·17 claims
- 0377US2025215079A1Antibodies specifically binding pd-1, tim-3 or pd-1 and tim-3 and their usesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0470US2023030983A1Fgfr/pd-1 combination therapy for the treatment of cancerASTEX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0567US12173064B2Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Dec 24, 2024·0 cites·30 claims
- 0665US2020108141A1Fgfr/pd-1 combination therapy for the treatment of cancerASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 0763US2025109211A1Methods of treating cancers and enhancing efficacy of bcmaxcd3 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0861US2024352140A1Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0958US12098210B2Methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2022·Granted Sep 24, 2024·0 cites·10 claims
- 1055US11952426B2Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2021·Granted Apr 9, 2024·0 cites·13 claims
- 1150US2022411525A1Bcma as a target for t cell redirecting antibodies in b cell lymphomasJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1249US2022348662A1Use of fgfr inhibitors in fgfr-genetically altered cancers to enhance patient response to immune checkpoint inhibitors in sequential treatment settingsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 1348US2022177584A1Methods for treating multiple myelomaJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1448US2023295292A1Methods of treating cancers and enhancing efficacy of gprc5dxcd3 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1538US11760801B2Anti-CEACAM antibodies and uses thereofJANSSEN BIOTECH INC·Filed 2020·Granted Sep 19, 2023·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Raluca Verona files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →